Engineered telomere degradation models dyskeratosis congenita

Dirk Hockemeyer, Wilhelm Palm, Richard C. Wang, Suzana S. Couto, Titia De Lange

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized by cutaneous symptoms, including hyperpigmentation and nail dystrophy. Some forms of DC are caused by mutations in telomerase, the enzyme that counteracts telomere shortening, suggesting a telomere-based disease mechanism. However, mice with extensively shortened telomeres due to telomerase deficiency do not develop the characteristics of DC, raising questions about the etiology of DC and/or mouse models for human telomere dysfunction. Here we describe mice engineered to undergo telomere degradation due to the absence of the shelterin component POT1b. When combined with reduced telomerase activity, POT1b deficiency elicits several characteristics of DC, including hyperpigmentation and fatal bone marrow failure at 4-5 mo of age. These results provide experimental support for the notion that DC is caused by telomere dysfunction, and demonstrate that key aspects of a human telomere-based disease can be modeled in the mouse.

Original languageEnglish (US)
Pages (from-to)1773-1785
Number of pages13
JournalGenes and Development
Volume22
Issue number13
DOIs
StatePublished - Jul 1 2008

Fingerprint

Dyskeratosis Congenita
Telomere
Telomerase
Telomere Shortening
Hyperpigmentation
Nails
Bone Marrow
Skin
Mutation
Enzymes

Keywords

  • Bone marrow failure
  • Dyskeratosis congenita
  • POT1
  • Shelterin
  • Telomerase
  • Telomere

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Engineered telomere degradation models dyskeratosis congenita. / Hockemeyer, Dirk; Palm, Wilhelm; Wang, Richard C.; Couto, Suzana S.; De Lange, Titia.

In: Genes and Development, Vol. 22, No. 13, 01.07.2008, p. 1773-1785.

Research output: Contribution to journalArticle

Hockemeyer, D, Palm, W, Wang, RC, Couto, SS & De Lange, T 2008, 'Engineered telomere degradation models dyskeratosis congenita', Genes and Development, vol. 22, no. 13, pp. 1773-1785. https://doi.org/10.1101/gad.1679208
Hockemeyer, Dirk ; Palm, Wilhelm ; Wang, Richard C. ; Couto, Suzana S. ; De Lange, Titia. / Engineered telomere degradation models dyskeratosis congenita. In: Genes and Development. 2008 ; Vol. 22, No. 13. pp. 1773-1785.
@article{389a03b8592e473d801adb6c3cf01010,
title = "Engineered telomere degradation models dyskeratosis congenita",
abstract = "Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized by cutaneous symptoms, including hyperpigmentation and nail dystrophy. Some forms of DC are caused by mutations in telomerase, the enzyme that counteracts telomere shortening, suggesting a telomere-based disease mechanism. However, mice with extensively shortened telomeres due to telomerase deficiency do not develop the characteristics of DC, raising questions about the etiology of DC and/or mouse models for human telomere dysfunction. Here we describe mice engineered to undergo telomere degradation due to the absence of the shelterin component POT1b. When combined with reduced telomerase activity, POT1b deficiency elicits several characteristics of DC, including hyperpigmentation and fatal bone marrow failure at 4-5 mo of age. These results provide experimental support for the notion that DC is caused by telomere dysfunction, and demonstrate that key aspects of a human telomere-based disease can be modeled in the mouse.",
keywords = "Bone marrow failure, Dyskeratosis congenita, POT1, Shelterin, Telomerase, Telomere",
author = "Dirk Hockemeyer and Wilhelm Palm and Wang, {Richard C.} and Couto, {Suzana S.} and {De Lange}, Titia",
year = "2008",
month = "7",
day = "1",
doi = "10.1101/gad.1679208",
language = "English (US)",
volume = "22",
pages = "1773--1785",
journal = "Genes and Development",
issn = "0890-9369",
publisher = "Cold Spring Harbor Laboratory Press",
number = "13",

}

TY - JOUR

T1 - Engineered telomere degradation models dyskeratosis congenita

AU - Hockemeyer, Dirk

AU - Palm, Wilhelm

AU - Wang, Richard C.

AU - Couto, Suzana S.

AU - De Lange, Titia

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized by cutaneous symptoms, including hyperpigmentation and nail dystrophy. Some forms of DC are caused by mutations in telomerase, the enzyme that counteracts telomere shortening, suggesting a telomere-based disease mechanism. However, mice with extensively shortened telomeres due to telomerase deficiency do not develop the characteristics of DC, raising questions about the etiology of DC and/or mouse models for human telomere dysfunction. Here we describe mice engineered to undergo telomere degradation due to the absence of the shelterin component POT1b. When combined with reduced telomerase activity, POT1b deficiency elicits several characteristics of DC, including hyperpigmentation and fatal bone marrow failure at 4-5 mo of age. These results provide experimental support for the notion that DC is caused by telomere dysfunction, and demonstrate that key aspects of a human telomere-based disease can be modeled in the mouse.

AB - Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized by cutaneous symptoms, including hyperpigmentation and nail dystrophy. Some forms of DC are caused by mutations in telomerase, the enzyme that counteracts telomere shortening, suggesting a telomere-based disease mechanism. However, mice with extensively shortened telomeres due to telomerase deficiency do not develop the characteristics of DC, raising questions about the etiology of DC and/or mouse models for human telomere dysfunction. Here we describe mice engineered to undergo telomere degradation due to the absence of the shelterin component POT1b. When combined with reduced telomerase activity, POT1b deficiency elicits several characteristics of DC, including hyperpigmentation and fatal bone marrow failure at 4-5 mo of age. These results provide experimental support for the notion that DC is caused by telomere dysfunction, and demonstrate that key aspects of a human telomere-based disease can be modeled in the mouse.

KW - Bone marrow failure

KW - Dyskeratosis congenita

KW - POT1

KW - Shelterin

KW - Telomerase

KW - Telomere

UR - http://www.scopus.com/inward/record.url?scp=46249089163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46249089163&partnerID=8YFLogxK

U2 - 10.1101/gad.1679208

DO - 10.1101/gad.1679208

M3 - Article

VL - 22

SP - 1773

EP - 1785

JO - Genes and Development

JF - Genes and Development

SN - 0890-9369

IS - 13

ER -